{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Descriptive statistics will be provided regarding incidence rates of toxicity. Patients will be monitored for safety throughout the study.","groups":[{"description":"Simvastatin and zoledronic acid: 1. Simvastatin 80 mg PO daily starting two days before starting chemotherapy and stopping two days after chemotherapy.\n\n2\\. Zoledronic acid 4 mg IV over 15 minutes on day 1 and then monthly.","id":"OG000","title":"Simvastatin and Zoledronic Acid"}],"populationDescription":"Study was terminated and PI has left the institution. Sincere efforts were made to gather and report the data, however, no data is available for the study","reportingStatus":"POSTED","timeFrame":"Every 12 months up to one month after treatment completion","title":"Incidence Rate of Toxicity","type":"SECONDARY"}